BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ansari N, Solomon MJ, Fisher RJ, Mackay J, Burmeister B, Ackland S, Heriot A, Joseph D, McLachlan SA, McClure B, Ngan SY. Acute Adverse Events and Postoperative Complications in a Randomized Trial of Preoperative Short-course Radiotherapy Versus Long-course Chemoradiotherapy for T3 Adenocarcinoma of the Rectum: Trans-Tasman Radiation Oncology Group Trial (TROG 01.04). Ann Surg. 2017;265:882-888. [PMID: 27631775 DOI: 10.1097/sla.0000000000001987] [Cited by in Crossref: 39] [Cited by in F6Publishing: 18] [Article Influence: 9.8] [Reference Citation Analysis]
Number Citing Articles
1 Ling DC, Vargo JA, Beriwal S. Breast, Prostate, and Rectal Cancer: Should 5-5-5 Be a New Standard of Care? Int J Radiat Oncol Biol Phys 2020;108:390-3. [PMID: 32890517 DOI: 10.1016/j.ijrobp.2020.06.049] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
2 Doi H, Yokoyama H, Beppu N, Fujiwara M, Harui S, Kakuno A, Yanagi H, Hishikawa Y, Yamanaka N, Kamikonya N. Neoadjuvant Modified Short-Course Radiotherapy Followed by Delayed Surgery for Locally Advanced Rectal Cancer. Cancers (Basel) 2021;13:4112. [PMID: 34439265 DOI: 10.3390/cancers13164112] [Reference Citation Analysis]
3 Li D, Li X, Yang F, Yuan R, Xiang Y. Targeted Delivery of DNA Framework-Encapsulated Native Therapeutic Protein into Cancer Cells. ACS Appl Mater Interfaces 2020;12:54489-96. [PMID: 33253532 DOI: 10.1021/acsami.0c17887] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
4 Oi H, Okuyama T, Miyazaki S, Ono Y, Oya M. CD133 Expression Predicts Relapse in Patients With Locally Advanced Rectal Cancer Treated With Neoadjuvant Chemotherapy. In Vivo 2021;35:437-45. [PMID: 33402494 DOI: 10.21873/invivo.12276] [Reference Citation Analysis]
5 Abdel-Rahman O, Elhalawani HM, Allen PK, Holliday EB. Utilization of short-course radiation therapy for patients with nonmetastatic rectal adenocarcinoma in the United States. Adv Radiat Oncol 2018;3:611-20. [PMID: 30370362 DOI: 10.1016/j.adro.2018.07.007] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
6 Studer G, Glanzmann C. [Radiation Oncology - Recent Status]. Praxis (Bern 1994) 2021;110:733-42. [PMID: 34583545 DOI: 10.1024/1661-8157/a003729] [Reference Citation Analysis]
7 Jeans EB, Jethwa KR, Harmsen WS, Neben-Wittich M, Ashman JB, Merrell KW, Giffey B, Ito S, Kazemba B, Beltran C, Haddock MG, Hallemeier CL. Clinical Implementation of Preoperative Short-Course Pencil Beam Scanning Proton Therapy for Patients With Rectal Cancer. Adv Radiat Oncol 2020;5:865-70. [PMID: 33083648 DOI: 10.1016/j.adro.2020.05.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
8 Feeney G, Sehgal R, Sheehan M, Hogan A, Regan M, Joyce M, Kerin M. Neoadjuvant radiotherapy for rectal cancer management. World J Gastroenterol 2019; 25(33): 4850-4869 [PMID: 31543678 DOI: 10.3748/wjg.v25.i33.4850] [Cited by in CrossRef: 45] [Cited by in F6Publishing: 31] [Article Influence: 22.5] [Reference Citation Analysis]
9 Sandra-Petrescu F, Herrle F, Burkholder I, Kienle P, Hofheinz RD. Influence of complete administration of adjuvant chemotherapy cycles on overall and disease-free survival in locally advanced rectal cancer: post hoc analysis of a randomized, multicenter, non-inferiority, phase 3 trial. BMC Cancer 2018;18:369. [PMID: 29614991 DOI: 10.1186/s12885-018-4309-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
10 Jin F, Luo H, Zhou J, Wu Y, Sun H, Liu H, Zheng X, Wang Y. Dose-time fractionation schedules of preoperative radiotherapy and timing to surgery for rectal cancer. Ther Adv Med Oncol 2020;12:1758835920907537. [PMID: 32165928 DOI: 10.1177/1758835920907537] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
11 Zhan TC, Zhang DK, Gu J, Li M. Surgical complications after different therapeutic approaches for locally advanced rectal cancer. World J Gastrointest Oncol 2019; 11(5): 393-403 [PMID: 31139309 DOI: 10.4251/wjgo.v11.i5.393] [Reference Citation Analysis]
12 Aghili M, Sotoudeh S, Ghalehtaki R, Babaei M, Farazmand B, Fazeli MS, Keshvari A, Haddad P, Farhan F. Preoperative short course radiotherapy with concurrent and consolidation chemotherapies followed by delayed surgery in locally advanced rectal cancer: preliminary results. Radiat Oncol J 2018;36:17-24. [PMID: 29621870 DOI: 10.3857/roj.2017.00185] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
13 Avila S, Chang GJ, Dasari NA, Smani DA, Das P, Herman JM, Koay E, Koong A, Krishnan S, Minsky BD, Smith GL, Taniguchi C, Taggart MW, Kaur H, Holliday EB. Pathologic Response and Postoperative Complications After Short-course Radiation Therapy and Chemotherapy for Patients With Rectal Adenocarcinoma. Clin Colorectal Cancer 2020;19:116-22. [PMID: 32173279 DOI: 10.1016/j.clcc.2020.02.005] [Reference Citation Analysis]
14 Larrea L, López E, Antonini P, González V, Berenguer MÁ, Baños MC, Bea J, Domingo J. COVID-19: hypofractionation in the Radiation Oncology Department during the 'state of alarm': first 100 patients in a private hospital in Spain. Ecancermedicalscience 2020;14:1052. [PMID: 32565905 DOI: 10.3332/ecancer.2020.1052] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
15 Geinitz H, Nieder C, Kocik L, Track C, Feichtinger J, Weingartner T, Spiegl K, Füreder-Kitzmüller B, Kaufmann J, Seewald DH, Függer R, Shamiyeh A, Petzer AL, Kiesl D, Hammer J. Altered fractionation short-course radiotherapy for stage II-III rectal cancer: a retrospective study. Radiat Oncol 2020;15:111. [PMID: 32410643 DOI: 10.1186/s13014-020-01566-8] [Reference Citation Analysis]
16 Tan L, Liu ZL, Ma Z, He Z, Tang LH, Liu YL, Xiao JW. Prognostic impact of at least 12 lymph nodes after neoadjuvant therapy in rectal cancer: A meta-analysis. World J Gastrointest Oncol 2020; 12(12): 1443-1455 [PMID: 33362914 DOI: 10.4251/wjgo.v12.i12.1443] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
17 Qiaoli W, Yongping H, Wei X, Guoqiang X, Yunhe J, Qiuyan L, Cheng L, Mengling G, Jiayi L, Wei X, Yi Y. Preoperative short-course radiotherapy (5 × 5 Gy) with delayed surgery versus preoperative long-course radiotherapy for locally resectable rectal cancer: a meta-analysis. Int J Colorectal Dis 2019;34:2171-83. [PMID: 31745621 DOI: 10.1007/s00384-019-03433-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
18 O'Cathail SM, Davis S, Holmes J, Brown R, Fisher K, Seymour L, Adams R, Good J, Sebag-Montefiore D, Maughan T, Hawkins MA. A phase 1 trial of the safety, tolerability and biological effects of intravenous Enadenotucirev, a novel oncolytic virus, in combination with chemoradiotherapy in locally advanced rectal cancer (CEDAR). Radiat Oncol 2020;15:151. [PMID: 32532291 DOI: 10.1186/s13014-020-01593-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
19 Song SH, Park JS, Kang MK, Choi GS, Park SY, Kim HJ, Kim JG, Kang BW, Baek JH, Baek DW, Kim JC, Park SH, Cho SH, Seo AN. Initial experience of preoperative short-course radiotherapy followed by oxaliplatin-based consolidation chemotherapy for locally advanced rectal cancer. Int J Colorectal Dis 2021;36:1279-86. [PMID: 33547945 DOI: 10.1007/s00384-021-03875-0] [Reference Citation Analysis]
20 Mir ZM, Yu D, Merchant SJ, Booth CM, Patel SV. Management of rectal cancer in Canada: an evidence-based comparison of clinical practice guidelines. Can J Surg 2020;63:E27-34. [PMID: 31967442 DOI: 10.1503/cjs.017518] [Reference Citation Analysis]